Peter van der Velden

Peter van der Velden is the managing general partner of Lumira Ventures, a Toronto-based life-sciences venture capital firm. He is recognized for his innovative approach to investing, particularly in the context of the new collaboration with the Terry Fox Foundation to create the Cancer Breakthrough Fund aimed at advancing cancer therapies. Van der Velden emphasizes the importance of the philanthropy-venture model in Canada, viewing it as a transformative method to enhance patient outcomes while also addressing the funding gap in the domestic market for early-stage life sciences.